Mark Skinner, JD

Represented: Patients, Caregivers, and Patient Advocates

Conflicts of Interest:

As of September 30, 2016:

• Institute for Policy Advancement, Ltd., President/CEO
• National Hemophilia Foundation, Consultant
• Workers Compensation Research Institute, Consultant
• World Federation of Hemophilia USA, President and Volunteer
• American Thrombosis and Hemostasis Network, Board of Directors Member
• Center for Medical Technology Policy Greenpark Collaborative Advisory Committee, Member
• National Hemophilia Foundation Medical and Scientific Advisory Council, Member
• HHS Advisory Committee on Blood Tissue Cell Safety and Availability (ACBTSA), Member
• Food and Drug Administration Center for Biologics Evaluation and Research (CBER), Temporary Voting Member (SGE Consultant)

Skinner served as a member of the Advisory Panel on Rare Disease from April 2014 - April 2017.